The Court asked why licenses had not been issued to as many reputed laboratories as possible, to ramp up production of the oral powder that has been approved to be used as an adjunct in treating COVID-19 patients
Read more here:: Post India Listing
Follow Our Network On LinkedIn: Follow link
Search India recent news in rumors and anything online listing
The Court asked why licenses had not been issued to as many reputed laboratories as possible, to ramp up production of the oral powder that has been approved to be used as an adjunct in treating COVID-19 patients
Read more here:: Post India Listing